This company has been acquired
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Prometheus Biosciences Bilan de santé
Santé financière contrôle des critères 6/6
Prometheus Biosciences has a total shareholder equity of $697.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $758.4M and $60.8M respectively.
Informations clés
0%
Ratio d'endettement
US$0
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$713.67m |
| Fonds propres | US$697.62m |
| Total du passif | US$60.80m |
| Total des actifs | US$758.41m |
Mises à jour récentes de la santé financière
We Think Prometheus Biosciences (NASDAQ:RXDX) Can Afford To Drive Business Growth
May 17
Here's Why We're Not Too Worried About Prometheus Biosciences' (NASDAQ:RXDX) Cash Burn Situation
Dec 03We Think Prometheus Biosciences (NASDAQ:RXDX) Needs To Drive Business Growth Carefully
Aug 19We're Hopeful That Prometheus Biosciences (NASDAQ:RXDX) Will Use Its Cash Wisely
May 04Prometheus Biosciences (NASDAQ:RXDX) Is In A Good Position To Deliver On Growth Plans
Nov 16Recent updates
We Think Prometheus Biosciences (NASDAQ:RXDX) Can Afford To Drive Business Growth
May 17Here's Why We're Not Too Worried About Prometheus Biosciences' (NASDAQ:RXDX) Cash Burn Situation
Dec 03We Think Prometheus Biosciences (NASDAQ:RXDX) Needs To Drive Business Growth Carefully
Aug 19Prometheus Biosciences GAAP EPS of -$0.86 beats by $0.06, revenue of $1.26M beats by $0.8M
Aug 11We're Hopeful That Prometheus Biosciences (NASDAQ:RXDX) Will Use Its Cash Wisely
May 04Prometheus: Biotech To Watch With A Monoclonal Antibody For Immune-Mediated Diseases
Dec 08Prometheus Biosciences (NASDAQ:RXDX) Is In A Good Position To Deliver On Growth Plans
Nov 16Prometheus Biosciences: Precision Medicine For IBD
Sep 22Analyse de la situation financière
Passif à court terme: RXDX's short term assets ($726.4M) exceed its short term liabilities ($19.3M).
Passif à long terme: RXDX's short term assets ($726.4M) exceed its long term liabilities ($41.5M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: RXDX is debt free.
Réduire la dette: RXDX had no debt 5 years ago.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: RXDX has sufficient cash runway for more than 3 years based on its current free cash flow.
Prévisions de trésorerie: RXDX has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 48.2% each year